Single-dose of adrecizumab versus placebo in acute cardiogenic shock (ACCOST-HH): an investigator-initiated, randomised, double-blinded, placebo-controlled, multicentre trial
Journal
-
- The Lancet Respiratory Medicine
-
The Lancet Respiratory Medicine 10 (3), 247-254, 2022-03
Elsevier BV
- Tweet
Details 詳細情報について
-
- CRID
- 1360017288156414208
-
- ISSN
- 22132600
-
- Data Source
-
- Crossref